TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/17/2025ACC: 0001601830-25-000147
Officer· Chief Financial Officer
Since Feb 2026
-7.06K
Net shares
Net seller
$34.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
7.06K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−7.06K
Price / share
$4.83
Trade value
$34.09K
% of position
0.9%
9/15/2025
811.23K→804.17K
Total
Net shares
−7.06K
Net value
-$34.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/15/2025 | F · Tax Withholding | −7.06K | $4.83 | $34.09K | 0.9% | 811.23K | 804.17K |
| Total | −7.06K | -$34.09K | ||||||
Derivative Transactions0
No derivative transactions reported